Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003091009 | SCV003467862 | pathogenic | MHC class II deficiency | 2022-09-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu124Cysfs*21) in the RFX5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RFX5 are known to be pathogenic (PMID: 7744245, 9401005, 10079298). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with major histocompatibility complex (MHC) class II deficiency (PMID: 34093558). For these reasons, this variant has been classified as Pathogenic. |